Baricitinib was generally well-tolerated. Acne was the most common adverse event (17.6%), followed by dyslipidemia (7.8%). Asthenia, elevated liver enzymes, and weight gain each occurred in fewer than ...

Positive data underscore Lilly's continued expansion across dermatologic conditions, with treatments that can improve outcomes for patients with the greatest need INDIANAPOLIS, March 8, 2025 ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Here are the top 5 most-viewed alopecia content in 2025.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. 42.4% of adolescents with severe alopecia areata who ...

Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) recently updated its clinical study ...

Patients with rheumatoid arthritis treated with baricitinib (Olumiant) were at increased risk for infection in a dose-dependent manner, a review of data from eight double-blind randomized trials and ...

Review the side-effects of Baricitinib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Janus kinase (JAK) inhibitors, including baricitinib, block cytokine signaling and are effective disease-modifying treatments for several autoimmune diseases. Whether baricitinib preserves β-cell ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The combination treatment is meant for patients who need supplemental oxygen, mechanical ...

A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, Type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients ...

SAN FRANCISCO — For patients with rheumatoid arthritis, baricitinib monotherapy is more effective than methotrexate monotherapy and more effective than the combination of methotrexate and baricitinib, ...